Li et al reported a model for predicting 2-year mortality for a patient hospitalized with advanced schistosomiasis. This can help to identify a patient who may require more aggressive management. The authors are from Huazhong University of Science and Technology in Wuhan, China.
Patient selection: hospitalized for advanced schistosomiasis
Parameters:
(1) age in years
(2) clinical assessment
(3) serum direct bilirubin
(4) serum AST
(5) serum alkaline phosphatase
(6) HBsAg reactivity
(7) serum alpha-fetoprotein
Parameter |
Finding |
Points |
age in years |
< 50 years |
1 |
|
50 to 59 years |
2 |
|
60 to 69 years |
3 |
|
70 to 79 years |
4 |
|
>= 80 years |
5 |
clinical assessment |
ascites |
0 |
|
splenomegaly |
1 |
direct bilirubin |
normal |
0 |
|
abnormal |
1 |
AST |
normal |
0 |
|
abnormal |
1 |
alkaline phophatase |
normal |
0 |
|
abnormal |
1 |
HBsAg |
negative |
0 |
|
positive |
1 |
alpha-fetoprotein |
normal |
0 |
|
abnormal |
1 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 1
• maximum score: 11
• The higher the score the greater the 2-year mortality.
Total Score |
2-Year Mortality |
1 |
0.7% |
2 |
1.4% |
3 |
2.8% |
4 |
5.5% |
5 |
10.7% |
6 |
20% |
7 |
35% |
8 |
52% |
9 |
67% |
Performance:
• The area under the ROC curve is 0.76 for internal and 0.72 for external validation cohorts.
Specialty: Infectious Diseases